News
Hosted on MSN27d
Lilly signs $1.3 billion deal with Superluminal to discover obesity medicines using AI
(Reuters) -Eli Lilly has signed a deal worth $1.3 billion with privately held Superluminal Medicines to discover and develop small-molecule drugs through AI to treat obesity and other cardiometabolic ...
Eli Lilly has signed a deal worth $1.3 billion with privately held Superluminal Medicines to discover and develop small-molecule drugs through AI to treat obesity and other cardiometabolic diseases.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback